Pande Vijay Satyanand
SEC insider (Form 3/4/5 filer). CIK 0001840663. Director at BioAge Labs, Inc. (BIOA). 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in EMERYVILLE, CA.
Companies Pande Vijay Satyanand has filed insider reports for
- BioAge Labs, Inc. (BIOA): Director
Pande Vijay Satyanand
CIK: 0001840663
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BioAge Labs, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 10, 2026BIOA
BioAge Labs, Inc.
AwardDirectStock Option (Right to Buy)
22K shares- - Aug 7, 2025BIOA
BioAge Labs, Inc.
AwardDirectStock Option (Right to Buy)
22K shares- - Oct 3, 2024BIOA
BioAge Labs, Inc.
PurchaseIndirect25.3K shares at avg. $19.90$504K - Oct 2, 2024BIOA
BioAge Labs, Inc.
PurchaseIndirect67.1K shares at avg. $19.73$1.3M - Oct 1, 2024BIOA
BioAge Labs, Inc.
PurchaseIndirect126.8K shares at avg. $19.73$2.5M - Sep 27, 2024BIOA
BioAge Labs, Inc.
ConversionIndirect856K shares- - Sep 27, 2024BIOA
BioAge Labs, Inc.
PurchaseIndirect900K shares at avg. $18.00$16.2M - Sep 27, 2024BIOA
BioAge Labs, Inc.
ConversionIndirect655.3K shares- - Sep 27, 2024BIOA
BioAge Labs, Inc.
ConversionIndirect189.6K shares- - Sep 27, 2024BIOA
BioAge Labs, Inc.
ConversionIndirect413.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | BIOA BioAge Labs, Inc. | Award Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| Aug 7, 2025 | BIOA BioAge Labs, Inc. | Award Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| Oct 3, 2024 | BIOA BioAge Labs, Inc. | Purchase | 25,306 | $19.90 | $503,589 | Indirect |
| Oct 2, 2024 | BIOA BioAge Labs, Inc. | Purchase | 67,096 | $19.73 | $1,323,804 | Indirect |
| Oct 1, 2024 | BIOA BioAge Labs, Inc. | Purchase | 126,793 | $19.73 | $2,501,626 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Conversion | 855,972 | - | $0 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Purchase | 900,000 | $18.00 | $16,200,000 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Conversion | 655,294 | - | $0 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Conversion | 189,609 | - | $0 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Conversion | 413,100 | - | $0 | Indirect |
1-10 of 10 transactions